From new imaging and targeted therapies to patient journeys, 2025 highlighted key advances and personal stories in lung ...

According to a 2025 survey conducted by the Prevent Cancer Foundation, only 51% of U.S. adults 21 and older say they have had ...

The survival rate among those with lung cancer has improved by more than a quarter in the last five years, according to a new report. Four years ago, the United States Preventive Services Task Force ...

Some cancers may not require immediate treatment, from prostate cancer to thyroid tumors. Medical experts share when ...

Patients with advanced bladder cancer have significantly less risk of the disease progressing or returning when treated with an immunotherapy drug called durvalumab, research has shown. Jörg ...

The survival rate for people with lung cancer is improving, according to the new State of Lung Cancer report. The American Lung Association report says there have been important advances in early ...

Reported 12-month overall survival (OS) in Phase 2a clinical trial nearly double the benchmark from pivotal study of standard ...

Radiation has been a staple of breast cancer treatment for decades, but a new study is casting doubt on whether it is ...

BEIJING -- China's pediatric and adolescent cancer patients have achieved a 5-year survival rate of 77.2 percent, marking significant progress, with some specific types reaching world-class levels, ...

The American Cancer Society’s Report on the Status of Cancer Disparities in the United States examines disparities in cancer occurrence and outcomes, and analyzes the factors that contribute to these ...

The world’s first early-detection blood test for pancreatic cancer is set to be launched in Australia, and is predicted to ...

Investing.com -- Immuneering Corporation (NASDAQ:IMRX) stock fell 20% after hours Wednesday despite announcing positive ...